InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (45 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
45
T+90 hit rate
63%
T+90 mean return
-2.4%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Betz Stephen F., Directeur Scientifique. Director active across 1 company, notably Crinetics Pharmaceuticals, Inc.. In total, 54 disclosures have been published. Split: 0 buy · 45 sells. Total volume traded: €4.6m. History available since 21 October 2021. The latest transaction was filed on 16 March 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations54 total
6,371 shares@ US$37.114.2% of flowCommon StockSEC:0001628280-26-019498:0
71,525 shares@ US$1.912.5% of flowCommon StockSEC:0000950170-25-086804:0
5,479 shares@ US$34.172.9% of flowCommon StockSEC:0000950170-25-043402:0
43,000 shares0Common StockSEC:0000950170-25-025664:0
2,331 shares@ US$1.910.1% of flowCommon StockSEC:0000950170-24-137923:0
1,035 shares@ US$51.500.8% of flowCommon StockSEC:0000950170-24-105952:0
3,000 shares@ US$53.192.4% of flowCommon StockSEC:0000950170-24-101434:0
3,000 shares@ US$47.682.2% of flowCommon StockSEC:0000950170-24-097085:0
3,000 shares@ US$53.432.5% of flowCommon StockSEC:0000950170-24-086935:0
3,000 shares@ US$48.552.3% of flowCommon StockSEC:0000950170-24-083221:0
3,000 shares@ US$45.372.2% of flowCommon StockSEC:0000950170-24-077905:0
3,000 shares@ US$43.862.1% of flowCommon StockSEC:0000950170-24-071971:0
3,000 shares@ US$47.492.2% of flowCommon StockSEC:0000950170-24-066657:0
3,000 shares@ US$49.432.3% of flowCommon StockSEC:0000950170-24-059865:0
3,655 shares@ US$38.142.2% of flowCommon StockSEC:0001209191-24-005010:0
23,000 shares0Common StockSEC:0001209191-24-004604:0
3,000 shares@ US$37.261.8% of flowCommon StockSEC:0001209191-24-002314:0
3,000 shares@ US$37.651.8% of flowCommon StockSEC:0001209191-24-001510:0
3,000 shares@ US$35.891.7% of flowCommon StockSEC:0001209191-23-059809:0
3,000 shares@ US$32.871.6% of flowCommon StockSEC:0001209191-23-058503:0
3,000 shares@ US$31.841.5% of flowCommon StockSEC:0001209191-23-056904:0
1,410 shares@ US$17.120.4% of flowCommon StockSEC:0001209191-23-019760:0
23,600 shares0Common StockSEC:0001209191-23-015578:0
3,126 shares@ US$19.591.0% of flowCommon StockSEC:0001209191-23-006872:0
8,336 shares@ US$21.072.8% of flowCommon StockSEC:0001209191-23-005252:0
25 of 54 declarations
About Betz Stephen F.
Stephen F. Betz is an executive at Crinetics Pharmaceuticals, Inc.
